Projects funded by the NCN

New hydrids of tetrahydroacridine derivatives as a acetylocholinesterase with multifunctional activity

Call: OPUS 10 , Panel: NZ7

Principal investigator: prof. Paweł Szymański

Uniwersytet Medyczny w Łodzi, Wydział Farmaceutyczny

Discovery and development of small-molecule inhibitors of USP2 for targeted, non-genotoxic therapy of cancer

Call: OPUS 1 , Panel: ST5

Principal investigator: prof. Tadeusz Holak

UNIWERSYTET JAGIELLOŃSKI, Wydział Chemii

Modification of cellular aging in vitro by inhibitors of non-enzymatic protein modifications

Call: OPUS 9 , Panel: NZ3

Principal investigator: prof. Grzegorz Bartosz

Uniwersytet Rzeszowski, Wydział Biologiczno-Rolniczy

Using X-ray crystallography for localization of the sites of binding of allosteric inhibitors and activators within the ...

Call: PRELUDIUM 9 , Panel: NZ1

Principal investigator: Julia Witkowska

Uniwersytet Gdański, Wydział Chemii

The expression of complement inhibitors in ovarian and corpus uteri cancers - a new perspective for immunotherapy

Call: SONATA 1 , Panel: NZ7

Principal investigator: dr hab. Lucyna Kapka-Skrzypczak

Wyższa Szkoła Informatyki i Zarządzania w Rzeszowie, Wydział Turystyki i Nauk o Zdrowiu

Investigation of the antitumor potential of stimulator of interferon genes (STING) - an adaptor protein in innate immune...

Call: PRELUDIUM 9 , Panel: NZ6

Principal investigator: Olga Sokołowska

Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese...

Call: OPUS 9 , Panel: ST5

Principal investigator: prof. Maria Bretner

Politechnika Warszawska, Wydział Chemiczny

New MOF compounds as degradable nanocontainers of tyrosine kinases inhibitors in novel anti-cancer therapy

Call: OPUS 9 , Panel: ST5

Principal investigator: prof. Artur Terzyk

Uniwersytet Mikołaja Kopernika, Wydział Chemii

The use of microRNA inhibitors for restoration of the expression of tumor suppressor, gene SLC5A8, and establishing of t...

Call: PRELUDIUM 9 , Panel: NZ2

Principal investigator: Wojciech Gierlikowski

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

Targeting histone deacetylases as an approach to treat neonatal asphyxia.

Call: PRELUDIUM 9 , Panel: NZ7

Principal investigator: Joanna Jaworska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

Call: PRELUDIUM 9 , Panel: NZ3

Principal investigator: Alicja Pawlak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

New approach in bisubstrate analogs inhibitors designing.

Call: PRELUDIUM 9 , Panel: NZ1

Principal investigator: dr Maria Winiewska-Szajewska

Instytut Biochemii i Biofizyki PAN

Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h...

Call: PRELUDIUM 9 , Panel: NZ5

Principal investigator: Zofia Bielecka

Wojskowy Instytut Medyczny